Inozyme Pharma, Inc. (INZY) Nonoperating Income (Expense) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Inozyme Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2024.
  • Inozyme Pharma, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $998 K, a 3.42% increase year-over-year.
  • Inozyme Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $4.51 M, a 71.8% increase year-over-year.
  • Inozyme Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $4.48 M, a 177% increase from 2022.
  • Inozyme Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $1.61 M, a 7236% increase from 2021.
  • Inozyme Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $22 K, a 96.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.51 M $998 K +$33 K +3.42% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $4.48 M $1.26 M +$275 K +27.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $4.2 M $1.44 M +$896 K +166% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.31 M $811 K +$681 K +524% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.62 M $965 K +$1.01 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.61 M $989 K +$986 K +32867% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $628 K $540 K +$558 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $70 K $130 K +$15 K +13% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $55 K -$45 K +$33 K +42.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $22 K $3 K -$150 K -98% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $172 K -$18 K -$239 K -108% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $411 K $115 K +$40 K +53.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $371 K -$78 K -$246 K -146% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $617 K $153 K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $221 K -$64 K -22.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $75 K -$305 K -80.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $168 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 $285 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $380 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.